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Abstract 
Langerhans cell histiocytosis (LCH), is a rare, proliferative disorder in which the accumulation of pathologic 
Langerhans cells leads to local tissue infiltration and destruction. We present a case of a 32 years old, completely 
edentulous female patient who presented with erythema of hard palate, maxillary alveolar mucosa and mucosa over 
the distobuccal part of mandibular alveolar ridge with foci of ulcerations. Histopathologic features were suggestive 
of LCH which was confirmed by immunohistochemistry which was CD1a positive, confirmatory for LCH. Bone 
scan revealed multiple bone involvement. At this stage, disease had already progressed to multisystem involvement 
with endocrinal abnormalities (primary hypothyroidism and hyperprolactinemia), requiring aggressive treatment. 
Therefore, this case is a reminder of the possibility of occurrence of this rare disease in the oral cavity which might 
manifest itself in multiple presentations thus easily leading to the misdiagnosis and therefore, it could be easily 
overlooked by dentists. 
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Introduction
Langerhans cell histiocytosis (LCH) is an uncommon di-
sorder of the dendritic Langerhans cell that lacks histolo-
gic evidence of malignancy but behaves in an aggressive 
manner. This disease has had many previous names in-
cluding eosinophilic granuloma, Hand-Christian-Schu-
ller disease, and Letterer-Siwe disease. A workshop in 
Philadelphia in 1985 recognized the common histologic 
and pathologic features of the disease, grouped them un-
der one heading, and the term LCH was adopted (1).
The disease usually occurs during childhood and the in-
cidence is one case per 200000 children per year, but 
it may also occur later in life (2). Etiology is unknown 
and various theories suggest a role for environmental, 
infectious, immunologic, genetic causes, and even some 
believe that LCH is a neoplastic process (3). Diagnos-
tic criteria have been well defined by the Writing Group 
of the Histiocyte Society (4). In addition to many the-
rapeutic combinations including surgery, chemotherapy 
and radiation new therapeutic strategies are represented 
by monoclonal CD-1a-antibody-therapy and gene trans-
fer into haemopoietic progenitor cells (5).
In this article, we report a case of LCH, which had pre-
sented with oral manifestations without any other sys-
temic signs and symptoms. But on complete work up 
the patient was diagnosed to have LCH with systemic 
involvement.
Case Report
A 32 year old female patient, mother of two children, 
poorly built and nourished reported to our clinics for re-
placement of her missing teeth. Patient also complained 
of burning sensation in the mouth since 1 yr. Patient had 
visited our department 2 years back with the complaint 
of pain in the gums and mobile teeth. Diagnosis of acu-
te necrotising ulcerative periodontitis was given. Teeth 
were not in a condition to be saved and all her teeth were 
extracted on follow up visits.  Patient also gave the me-
dical history of amenorrhea after the delivery of her 2nd 
child 6 years back.
Clinical examination showed severely resorbed maxi-
llary and mandibular alveolar ridges. Erythema of hard 
palate, maxillary alveolar mucosa and distobuccal por-
tion of mandibular alveolar mucosa bilaterally was 
present with foci of ulcerations (Fig. 1). On palpation 
mucosa over the hard palate was non tender, soft and 
oedematous in consistency with no discharge from the 
lesions. Noma was given as provisional diagnosis and 
tuberculous ulcer, ulcerative stomatitis secondary to 
malnutrition, chronic major apthous ulcers and necro-
tising sialometaplasia were considered as differential 
diagnosis. Occlusal and panoramic radiograph, routine 
blood investigations, test to rule out tuberculosis and 
HIV and incisional biopsy were carried out.  Panora-
mic radiograph revealed extensive bony destruction in 
the maxilla and mandible. Blood investigations showed 
increased erythrocyte sedimentation rate and decreased 
haemoglobin level. White cell count and random blood 
glucose value were within normal range. Mantoux test 
was negative and HIV antibody tests were non-reactive. 
Histopathologic study revealed diffuse dense chro-
nic inflammatory cell infiltrate and cells with reniform 
nuclei suggestive of abnormal Langerhans cells in the 
connective tissue. To confirm the lesional Langerhans 
cells, immunohistochemical staining for CD1a which is 
diagnostic for it was performed (6) (Fig. 2). The result 
Fig. 1. Oral lesions in the hard palate and  maxillary alveolar ridge.
Fig. 2. Expression of CD1a antigen in oral mucosal biopsy demons-
trating infiltrated Langerhans cells with the cytoplasmic membranous 
expression of the antigen.
was positive and final diagnosis of Langerhans cell his-
tiocytosis was given. To evaluate the generalized bony 
involvement plain radiography of skull, chest and limbs 
were done and no abnormality was detected. Bone scan 
was carried out further and the results revealed increased 
tracer uptake in the mandible, pelvis: left iliac bone and 
right pubis, bilateral femori, right proximal femur, bila-
teral tibiae and abnormal uptake in the lumbar vertebrae 
(Fig. 3). Endocrine opinion was taken and investigations 
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revealed altered levels of thyroid stimulating hormone, 
prolactin, follicle stimulating hormone and luteinizing 
hormone (Table 1). Patient was diagnosed to have pri-
mary hypothyroidism and hyperprolactinemia. Opinion 
of oncology department was taken and ultrasonography 
of abdomen was advised. Ultrasonography revealed 
bulky pancreas with hypoechoic echotexture. Based on 
histological and other previously mentioned positive in-
vestigatory findings the diagnosis of LCH with systemic 
involvement was established.
Patient was referred to the department of medical onco-
logy. Chemotherapy was planned, including 6 cycles of 
vinblastine (10 mg weekly) and systemic prednisolone 
(10 mg thrice a day) for 6 weeks. For oral lesions no 
treatment was undertaken except for 0.12% chlorhexidi-
ne daily rinse. Hormonal replacement therapy was plan-
ned after the chemotherapy.
Before third cycle of chemotherapy patient’s total leuco-
cyte count (TLC) fell down to 730/cu mm and granulocy-
te- colony stimulating factor( 300 mcg subcutaneously) 
was given following which TLC raised to 65,990/cu mm. 
Third cycle was administered but the patient’s condition 
deteriorated, patient was brought to the emergency unit 
in a semi-consciousness state. Her random blood gluco-
se level, blood urea nitrogen, serum creatinine was high 
and electrolytic imbalance was present. Unfortunately 
patient succumbed to the complications of the disease.
Discussion
Langerhans cell histiocytosis is seen rarely in adults, and 
affects only 1-2/million.  Thirty percent of cases present 
with lesions that affect the jaws. Recognition of this 
disease is problematic as the clinical and radiographic 
features are not pathognomonic. Buchmann et al (7) re-
ported that average time to diagnosis was 25 weeks and 
ranged from 3 to 60 weeks. The oral findings may be 
pain, mucosal ulceration, gingival necrosis and destruc-
tion of alveolar bone with tooth mobility and exfoliation 
as in our case.
Radiologically, LCH presents as localized, punched-out 
radiolucencies with no calcification and no sign of scle-
rosis or reactions at the borders. There may be severe 
alveolar bone resorption producing the appearance of 
teeth ‘‘floating in space’’ (8) as in our case. These non 
pathognomonic clinical and radiographic features led to 
the diagnosis of acute nectrotizing ulcerative periodon-
titis in first place and there was a delay of 90 weeks in 
diagnosis of LCH.
As LCH lacks pathognomonic clinical or radiographic 
characteristics, a definitive diagnosis should be based on 
the histologic and immunohistochemical study of lesio-
nal biopsy specimens, where positivity is characteristi-
cally observed for CD1a, langerin (CD207) and S-100 
protein (9). Because monoclonal proliferation of CD1-
positive histiocytes has been shown in all forms of LCH 
disease, the narrow specificity of the antibody and the 
ease of the immune staining process render immunos-
taining for CD1a useful as a routine procedure for diag-
nostic confirmation of LCH (6).  As in our case CD1a 
immunostaining was positive and hence confirmatory 
for LCH.
As LCH can be a multifocal disease, radiographic skele-
tal surveys to be a reasonable procedure for a complete 
evaluation of the bone condition. In addition, extra ske-
letal involvement is more likely in patients with multiple 
bony lesions (10). A bone scintigraphy can also be useful 
to exclude or to detect additional bone lesions and to 
follow up patients (9). Full body bone scan in our case 
revealed multiple bone involvements. Anterior pituitary 
dysfunction has been described in up to 20% of patients 
with LCH, usually associated with diabetes insipidus 
Fig. 3. Bone scan was showing increased tracer uptake in the man-
dible, pelvis: left iliac bone and right pubis, bilateral femori, right 
proximal femur, bilateral tibiae and abnormal uptake in the lumbar 
vertebrae.
INVESTI-
GATIONS
RESULTS
BIOLOGICAL REFE-
RENCE INTERVAL
T4 5.5 µg/dl 5.50-11.00
TSH (thyroid 
stimulating 
hormone)
13.067µIU/ml 0.400-4.200
Prolactin 70.14ng/ml
3.80-23.0 ( Nonpregnant)
95.0-473.0 (Pregnant- 3rd               
trimester)
FSH (follicle-
stimulating 
hormone)
0.76 mIU/ml
1.40-9.90 (Follicular phase)
0.20-17.20 (Midcycle peak)
1.10-9.20 (Luteal phase)
19.3-100.6 (Postmenopausal)
LH (lu-
teinizing 
hormone)
<0.01 mIU/ml
1.7-15.0 (Follicular phase)
21.9-56.6 (Midcycle peak)
0.6-16.3 (Luteal phase)
14.2-52.3 (Postmenopausal) 
Table 1. Endocrinological investigations.
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(11). In our case anterior pituitary dysfunction was pre-
sent without diabetes insipidus. 
The treatment of LCH is dependent on lesion size, the 
degree of tissue involvement and whether it is unifo-
cal or multifocal. Therapy includes surgery, radiation, 
and chemotherapy, either individually or in combina-
tion. Chemotherapy (methotrexate and vinblastine with 
prednisone) is provided for the more disseminated cases 
(12). As in our case there was multifocal and systemic 
involvement, chemotherapy was instituted to the patient. 
Clinical prognosis of patients become worse with the 
growing number of involved organs, with rapid disease 
progression, with limited treatment response and decrea-
sing age of first disease manifestation (8). Recurrence 
rates depend on the treatment method and location of the 
lesion and are reported to range from 1.6% to 25% and 
patients should be closely followed up for a long period 
of time (10). 
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